One of the top hospitals for breast cancer treatment in Tamil Nadu is the Hospitals in Chennai. With a dedicated breast cancer clinic, it offers comprehensive care including advanced diagnostics, surgery, chemotherapy, and radiation therapy. The hospital boasts a team of experienced oncologists, sur

3 views • 4 slides

Explore the BreastScreen Victoria Program, learn about breast cancer risk factors, early detection, and survival rates in Australia. Discover how to reduce your risk, be breast aware, and recognize normal breast changes. Find out how the program is delivered and the difference between breast screeni

2 views • 23 slides

Exploring breast cancer epidemiology, risk factors, facts, signs/symptoms, and screening guidelines, with a focus on disparities faced by AmeriHealth Caritas members in Louisiana. Details on the impact of income, early detection rates, and the LA Breast and Cervical Health Program offering mammogram

0 views • 15 slides

Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

Breast pain, characterized by tenderness, throbbing, sharp, or burning sensations in the breast tissue, can affect individuals of all genders. This common symptom may vary in severity and frequency, and is typically not associated with cancer. The Breast Pain Pathway outlines the management of breas

2 views • 13 slides

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides

Breast cancer is the most common cancer among women around the globe. However, in comparison to the developed nations, India\u2019s cancer incidence is far lower. Nevertheless, the death rates are still higher due to late detection.

1 views • 3 slides

This guideline developed in collaboration with various oncology societies offers recommendations for partial breast irradiation (PBI) in patients with early-stage invasive breast cancer or ductal carcinoma in situ. It covers patient selection criteria, techniques for delivering PBI, dosing, and trea

1 views • 27 slides

The Ontario Breast Screening Program (OBSP) is a quality-assured, population-based breast cancer screening initiative administered by Cancer Care Ontario. It aims to reduce breast cancer mortality through early detection by providing biennial screenings for average-risk women aged 50-74 and annual s

3 views • 21 slides

POSNOC (Positive Sentinel Node) and ATNEC trials are investigating the effectiveness of axillary treatment in women with early-stage breast cancer having metastases in one or two sentinel nodes. Led by Chief Investigator Amit Goyal in the UK, this randomized controlled trial compares adjuvant therap

1 views • 21 slides

Breast health is crucial for every woman, and regular breast examinations play a significant role in early detection of abnormalities and breast cancer. This comprehensive guide covers different screening methods, assessment interviews, clinical breast examinations, and what to look for during a bre

0 views • 24 slides

This informative content covers topics such as urethral catheterization, indications for catheterization, anatomic landmarks, male and female catheterization techniques, nosocomial UTIs, pelvic and breast examinations, breast cancer screening recommendations, and breast cancer statistics. It is a co

0 views • 17 slides

Benign breast conditions can manifest in various ways, including pain, palpable masses, and nipple discharge. Familiarity with common inflammatory conditions like mastitis and abscesses, as well as understanding fibrocystic changes and benign tumors such as fibroadenoma, is crucial. Mammographic scr

0 views • 15 slides

Recent research highlights the importance of genetic testing for cancer susceptibility genes in breast cancer patients to guide personalized treatment plans. Guidelines based on pathogenic variants in genes like BRCA1, BRCA2, and others provide insights on relative cancer risks and recommendations f

0 views • 21 slides

This document provides updates on breast cancer research, focusing on recruitment data and studies conducted between 2019 and 2023. It includes information on national and regional recruitment to breast cancer studies, SWAG region lead network studies, and opened breast cancer studies in 2022/2023.

0 views • 13 slides

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides

Breast cancer molecular subtypes play a crucial role in determining survival outcomes. This study by Nadia Howlader, PhD, from the National Cancer Institute, presented the first nationally representative estimates of breast cancer survival by four main molecular subtypes. The research aimed to under

1 views • 23 slides

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

1 views • 11 slides

Recent scientific presentations shed light on delayed diagnosis of breast cancer in young women, highlighting the need for increased education and awareness. Findings indicate a concerning rate of delayed diagnoses, with many patients lacking essential breast health education. Moreover, research on

5 views • 11 slides

This study explores the relevance and effectiveness of breast cancer screening for women aged 70 and above, utilizing data from the Auckland Breast Cancer Registry. It examines demographics, cancer presentation modes, characteristics, and long-term outcomes to address the question of whether screeni

0 views • 32 slides

Clinical Nurse Specialists (CNS) play a crucial role in supporting breast cancer patients during consultations in various healthcare facilities in Somerset, Wiltshire, Avon, and Gloucestershire. Their presence ensures patients receive personalized care, support, and clarity on their diagnosis and tr

0 views • 6 slides

National and local workforce planning, improved NHS structures, effective data collection, and service improvement are key recommendations for addressing geographical inequalities in breast cancer care. Clinical advice emphasizes the importance of collecting relevant data, optimal treatment planning

0 views • 6 slides

The Ohio Breast and Cervical Cancer Project (BCCP) celebrates its 30th anniversary by offering crucial screening and diagnostic services for Ohio women at or below 300% of the federal poverty level. The program has seen an increase in the number of women served annually, reaching over 6,000 per year

1 views • 18 slides

Breast cancer is heterogeneous, and predicting outcomes using clinical and pathologic features can be challenging. Genomic tests such as Oncotype DX, PAM50, and MammaPrint have been developed to aid in treatment decisions since 2002. Studies like the NSABP B-14 and B-20 trials have shown the benefit

0 views • 45 slides

Complementary therapies (CT) use, including natural medicine and homeopathy, is on the rise among individuals with and without a breast cancer diagnosis in Chile. While some CTs are not included in the official healthcare package, there is increasing interest in incorporating them due to high satisf

0 views • 4 slides

Menopausal symptoms can significantly impact the quality of life for breast cancer survivors, affecting their tolerance of treatments and overall well-being. Understanding the causes and management strategies for these symptoms is crucial to support these individuals through their post-cancer journe

0 views • 28 slides

Alcohol consumption is linked to an increased risk of various cancers, including mouth, throat, esophagus, breast, liver, and colorectal cancers. Factors such as ethanol, acetaldehyde, nutrient absorption, estrogen levels, and liver cirrhosis play a role in this risk. Even light drinking can elevate

0 views • 17 slides

The journey of cancer diagnosis brings forth various challenges, including misconceptions about nutrition. Debunking myths like soy stimulating cancer cells, sugar feeding cancer, and acidic diets curing cancer is crucial for informed decision-making. Evidence shows that soy can be a part of a healt

1 views • 11 slides

Lead by Catherine Neck, the Macmillan Cancer Rehabilitation/Recovery Package Project aims to enhance cancer care services. The Cancer Transformation Funding supports initiatives for breast, colorectal, and prostate cancers, including holistic needs assessments and wellbeing events. The SWAG Cancer A

0 views • 7 slides

This presentation discusses the use of near-infrared (NIR) spectral methods for rapid and reagent-free drug testing in Africa. The focus is on deploying low-cost infrared devices for verifying medicines, building databases on genuine medicines, and enhancing the capacities of drug professionals thro

0 views • 12 slides

The data presented showcases global cancer statistics from various years, highlighting the prevalence of different types of cancer across genders. It includes information on the estimated number of cancer cases, common types of cancers, and trends expected up to 2035. Lung cancer, breast cancer, and

0 views • 83 slides

This tutorial, prepared by the International Working Group for TIL in breast cancer, provides guidelines for pathologists on the standardized evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer based on H&E slides of core biopsies or tumor resections. It details steps such as defini

0 views • 14 slides

This event on March 2, 2021, gathered experts in the field to discuss the optimal management of HER2-positive breast cancer. The agenda covered topics such as early breast cancer management, treatment sequencing for metastatic disease, and real-life case scenarios. Speakers shared insights on COVID-

0 views • 50 slides

The SWAG.Network Breast Cancer Clinical Advisory Group Research Update by Claire Matthews discusses the latest developments in breast cancer studies from April 2020 to March 2022. It covers national recruitment data, comparison between national and regional recruitment, and details of ongoing studie

0 views • 9 slides

Ongoing breast cancer research projects focusing on biomarker validation, new team initiatives, and imaging advancements are detailed. Notable efforts include the investigation of triple-negative breast cancer markers, benign breast disease progression markers, ER+ and HER2+ biomarkers, and breast c

0 views • 9 slides

This chapter outlines the strategic actions and essential supply needs for establishing a breast cancer screening and early diagnosis service. It covers ISO 9001:2015 certified procedures, human resource requirements, rapid diagnostic clinic setup, necessary medical devices, and planned implementati

0 views • 19 slides

Breast cancer, particularly estrogen receptor-positive tumors, poses a significant challenge due to endocrine resistance. While endocrine therapy is effective, resistance can occur in both early and advanced stages of the disease. This presentation discusses novel approaches to address this resistan

0 views • 21 slides

The complex cancer late effects rehabilitation service (CCLERS) and breast radiation injury rehabilitation service (BRIRS) offer specialized care for individuals experiencing chronic pain, reduced limb function, and psychological distress following cancer treatment. BRIRS provides support for brachi

0 views • 11 slides

Learn about the spending on various types of cancer in Europe including breast cancer, colorectal cancer, prostate cancer, lung cancer, ovary cancer, and pancreatic cancer. The information is based on the Comparator Report on Cancer in Europe 2019, which covers disease burden, costs, and access to m

1 views • 7 slides

The presentation by Professor Bengt Jönsson highlights the evolving landscape of cancer burden and costs in Europe, emphasizing the increasing mortality rates in certain age groups. Despite a decrease in deaths in those under 65, cancer remains a significant contributor to Disability Adjusted Life

0 views • 14 slides